0
November 2006, Vol 160, No. 11 >
Corrections | November 2006

Errors in Figures in: A Randomized Controlled Trial Testing an HIV Prevention Intervention for Latino Youth FREE

Arch Pediatr Adolesc Med. 2006;160(11):1187. doi:10.1001/archpedi.160.11.1187.
Text Size: A A A
Published online
Article
Figures
Comments

Errors in Figures. In the Article by Villarruel et al titled “A Randomized Controlled Trial Testing an HIV Prevention Intervention for Latino Youth,” published in the August issue of the ARCHIVES (2006;160:772-777), errors occurred in the symbol keys of Figures 2, 3, and 4 on page 775. The keys should have indicated that the squares represent the health-promotion group and the diamonds represent the human immunodeficiency virus (HIV) risk-reduction group. The corrected figures are reprinted here with their legends.

Place holder to copy figure label and caption
Figure 2.

Self-report of sexual intercourse in the past 3 months. This graph does not represent results of generalized estimation equation analyses. The percentage (SE) was calculated for the outcome variable; unadjusted scores are presented for each time period. Values for the human immunodeficiency virus (HIV) risk-reduction group are as follows: pretest, 25.9% (0.44%); 3 mo, 26.0% (0.44%); 6 mo, 28.4% (0.45%); and 12 mo, 35.7% (0.48%). Values for the health-promotion group are as follows: pretest, 28.4% (0.45%); 3 mo, 31.0% (0.46%); 6 mo, 33.3% (0.47%); and 12 mo, 40.7% (0.49%).

Grahic Jump Location
+Image not available.
View Large  |  Save Figure  |  Download Slide (.ppt)  |  View in Article Context
Image not available.

Place holder to copy figure label and caption
Figure 3.

Self-report of multiple partners in the past 3 months. This graph does not represent results of generalized estimation equation analyses. The percentage (SE) was calculated for the outcome variable; unadjusted scores are presented for each time period. Values for the human immunodeficiency virus (HIV) risk-reduction group are as follows: pretest, 10.4% (0.31%); 3 mo, 14.0% (0.35%); 6 mo, 9.0% (0.29%); and 12 mo, 10.7% (0.31%). Values for the health-promotion group are as follows: pretest, 7.8% (0.27%); 3 mo, 11.7% (0.32%); 6 mo, 10.3% (0.30%); and 12 mo, 17.3% (0.38%).

Grahic Jump Location
+Image not available.
View Large  |  Save Figure  |  Download Slide (.ppt)  |  View in Article Context
Image not available.

Place holder to copy figure label and caption
Figure 4.

Consistent condom use in the past 3 months. This graph does not represent results of generalized estimation equation analyses. The percentage (SE) was calculated for the outcome variable; unadjusted scores are presented for each time period. Scores were calculated only for participants who were sexually active at baseline (human immunodeficiency virus [HIV] risk-reduction group [n=106], health-promotion group [n=127]). Values for the HIV risk-reduction group are as follows: pretest, 46.8% (0.50%); 3 mo, 42.6% (0.50%); 6 mo, 44.8% (0.50%); and 12 mo, 42.2% (0.50%). Values for the health-promotion group are as follows: pretest, 34.8% (0.48%); 3 mo, 25.7% (0.44%); 6 mo, 28.8% (0.46%); and 12 mo, 27.6% (0.45%).

Grahic Jump Location
+Image not available.
View Large  |  Save Figure  |  Download Slide (.ppt)  |  View in Article Context
Image not available.

Figures

Place holder to copy figure label and caption
Figure 2.

Self-report of sexual intercourse in the past 3 months. This graph does not represent results of generalized estimation equation analyses. The percentage (SE) was calculated for the outcome variable; unadjusted scores are presented for each time period. Values for the human immunodeficiency virus (HIV) risk-reduction group are as follows: pretest, 25.9% (0.44%); 3 mo, 26.0% (0.44%); 6 mo, 28.4% (0.45%); and 12 mo, 35.7% (0.48%). Values for the health-promotion group are as follows: pretest, 28.4% (0.45%); 3 mo, 31.0% (0.46%); 6 mo, 33.3% (0.47%); and 12 mo, 40.7% (0.49%).

Grahic Jump Location
+Image not available.
View Large  |  Save Figure  |  Download Slide (.ppt)  |  View in Article Context
Image not available.
Place holder to copy figure label and caption
Figure 3.

Self-report of multiple partners in the past 3 months. This graph does not represent results of generalized estimation equation analyses. The percentage (SE) was calculated for the outcome variable; unadjusted scores are presented for each time period. Values for the human immunodeficiency virus (HIV) risk-reduction group are as follows: pretest, 10.4% (0.31%); 3 mo, 14.0% (0.35%); 6 mo, 9.0% (0.29%); and 12 mo, 10.7% (0.31%). Values for the health-promotion group are as follows: pretest, 7.8% (0.27%); 3 mo, 11.7% (0.32%); 6 mo, 10.3% (0.30%); and 12 mo, 17.3% (0.38%).

Grahic Jump Location
+Image not available.
View Large  |  Save Figure  |  Download Slide (.ppt)  |  View in Article Context
Image not available.
Place holder to copy figure label and caption
Figure 4.

Consistent condom use in the past 3 months. This graph does not represent results of generalized estimation equation analyses. The percentage (SE) was calculated for the outcome variable; unadjusted scores are presented for each time period. Scores were calculated only for participants who were sexually active at baseline (human immunodeficiency virus [HIV] risk-reduction group [n=106], health-promotion group [n=127]). Values for the HIV risk-reduction group are as follows: pretest, 46.8% (0.50%); 3 mo, 42.6% (0.50%); 6 mo, 44.8% (0.50%); and 12 mo, 42.2% (0.50%). Values for the health-promotion group are as follows: pretest, 34.8% (0.48%); 3 mo, 25.7% (0.44%); 6 mo, 28.8% (0.46%); and 12 mo, 27.6% (0.45%).

Grahic Jump Location
+Image not available.
View Large  |  Save Figure  |  Download Slide (.ppt)  |  View in Article Context
Image not available.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems